Literature DB >> 14585646

European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287.

David J Flavell, Sopsamorn U Flavell, Richard Sullivan.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14585646     DOI： 10.1016/S0140-6736(03)14646-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Implementing the European clinical trials directive.

Authors:  Kent Woods
Journal:  BMJ       Date:  2004-01-31

2.  Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health.

Authors:  James D Neaton; Abdel Babiker; Mark Bohnhorst; Janet Darbyshire; Eileen Denning; Arnie Frishman; Jesper Grarup; Gregg Larson; Jens Lundgren
Journal:  Clin Trials       Date:  2010-08-20       Impact factor: 2.486

Review 3.  Clinical trials in paediatric haematology-oncology: are future successes threatened by the EU directive on the conduct of clinical trials?

Authors:  Chris Mitchell
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

4.  The unintended consequences of clinical trials regulations.

Authors:  Alex D McMahon; David I Conway; Tom M Macdonald; Gordon T McInnes
Journal:  PLoS Med       Date:  2009-11-17       Impact factor: 11.069
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.